新型香豆素类抗HIV-RT/PR的活性及其构效关系研究

基本信息
批准号:39970868
项目类别:面上项目
资助金额:17.00
负责人:董飙
学科分类:
依托单位:中国医学科学院
批准年份:1999
结题年份:2002
起止时间:2000-01-01 - 2002-12-31
项目状态: 已结题
项目参与者:董飙,曹鸿鹏,章天,王琳,高琦,钱炼,王光星,张兴权
关键词:
HIV逆转录酶HIV蛋白酶酶的抑制剂合成
结项摘要

Coumarin derivatives has been demonstrated in our lab to inhibit the activity of human immunodeficiency virus type 1(HIV-1) reverse trancriptase(RT) and HIV-1 protease(PR) in cell free system. It also show inhibition effects on HIV replication in cell culture. Based on the chinese traditional pharmacological characteristic and protein three dimension computer aided design, analoges of tetracyclic dipyranocoumarin were synthesized from natural leading compounds, including two natural products Cordatolide A and Inophyllum B. We studied the relationship of antiviral effects and chemical structures via HIV-1 PR/RT enzyme models and tissue culture model system. 65 compounds were designed and tested. According to our experiment data, V9722, which is an analog of calanolide A, showed significant inhibition effect on HIV-1 RT with IC50 of HIV-1 RT of wild strain and resistant strain of 3.17μM and 0.114μM, respectively. In cell culture V9722 was demonstrated the anti-HIV-1 replication activities in various cell cultures against different HIV-1 wild strains and resistant strains. It also showed synergic anti-HIV-1 activities with AZT, indinavir and T-20. Compounds V0201 targated against HIV-1 PR/RT with IC50 of 3.16μM and 0.78μM, respectively. V0201 is a highly active inhibitor with IC50 0.037μM in cell culture. These experiment data indicate that our both design strategies are successful to obtain new anti-HIV agents in which V0201 is a novel structure and maybe a new leading compound. We concluded these new compounds are worth to develop new anti-HIV drugs in the future.

在既往研究中发现不同香豆素衍生物具有抑制HIV-1 RT 或HIV-1 PR活性,且在细胞培养内显示抑制HIV复制作用。本课题根据国内传统药学特点,以天然产物为先导物,结合蛋酌溉峁辜扑慊ㄖ杓疲铣扇芳八幕匪拎愣顾匮苌铮礁鎏烊徊顲ordatolide A 及Inophyllum B。以HIV RT及HIV PR为靶点,进行构效关系研究,以期为发展夜笻IV药物提供有效化合物。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

组蛋白去乙酰化酶在变应性鼻炎鼻黏膜上皮中的表达研究

组蛋白去乙酰化酶在变应性鼻炎鼻黏膜上皮中的表达研究

DOI:10.16066/j.1672-7002.2021.06.013
发表时间:2021
2

SUMO特异性蛋白酶3通过调控巨噬细胞极化促进磷酸钙诱导的小鼠腹主动脉瘤形成

SUMO特异性蛋白酶3通过调控巨噬细胞极化促进磷酸钙诱导的小鼠腹主动脉瘤形成

DOI:10.3969/j.issn.1000-4718.2020.05.001
发表时间:2020
3

Fe-Si合金在600℃不同气氛中的腐蚀

Fe-Si合金在600℃不同气氛中的腐蚀

DOI:DOI: 10.11902/1005.4537.2013.169
发表时间:2014
4

一类随机泛函微分方程带随机步长的EM逼近的渐近稳定

一类随机泛函微分方程带随机步长的EM逼近的渐近稳定

DOI:10.21656/1000-0887.390057
发表时间:2019
5

基于 RDD关键度的Spark检查点管理策略

基于 RDD关键度的Spark检查点管理策略

DOI:10.7544?issn1000-1239.2017.20160717
发表时间:2017

董飙的其他基金

相似国自然基金

1

新型香豆素类化合物的设计、合成、抗单殖吸虫活性及构效关系研究

批准号:31902419
批准年份:2019
负责人:刘广路
学科分类:C1908
资助金额:24.00
项目类别:青年科学基金项目
2

以ArgR为靶标的新型4-羟基香豆素类抗菌药物构效关系及其机制研究

批准号:81573468
批准年份:2015
负责人:李明凯
学科分类:H3506
资助金额:60.00
项目类别:面上项目
3

香豆素衍生物的设计、合成、构效关系及光敏活性研究

批准号:21162007
批准年份:2011
负责人:骆焱平
学科分类:B0706
资助金额:50.00
项目类别:地区科学基金项目
4

基于cmER靶点的新疆阿魏树脂中倍半萜香豆素类抗宫颈癌活性成分及构效关系研究

批准号:81903920
批准年份:2019
负责人:王钧篪
学科分类:H3218
资助金额:21.00
项目类别:青年科学基金项目